The market will reward resilient growth names, PM says.
The global economic outlook is less positive.
The pandemic, geopolitics and valuations pose risks, PM says.
Some firms are better prepared to weather the volatility.
At this point in the recovery, PM prefers tech and health care.
Market-leading companies could distance themselves from smaller competitors.
Investors should be vigilant about valuations.
Vaccines, therapeutics provide growth opportunities.
Vaccine development is a topical but tricky area.
An investment manager finds companies built to survive the pandemic.